Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Irbesartan and Hydrochlorothiazide Milpharm 300 mg/ 12.5 mg film-coated tablets

Active Ingredient:
hydrochlorothiazide, irbesartan
Company:  
Aurobindo Pharma - Milpharm Ltd. See contact details
ATC code: 
C09DA04
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials HCP Med Info
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Irbesartan/HCTZ- HCP letter- Hydrochlorothiazide and the risk of non-melanoma skin cancer

{healthcare_pro_orange} For Healthcare Professionals

The prescriber should inform the patients taking hydrochlorothiazide (HCTZ) containing medicines of the risk of non-melanoma skin cancer. Patients should be advised to limit the exposure to sunlight and UV rays and use adequate protection when exposed to sunlight and UV rays to minimise the risk of skin cancer

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Aurobindo Pharma - Milpharm Ltd.
Company image
Address
Odyssey Business Park, Ares Block, West End Road, South Ruislip, Middlesex, HA4 6QD
WWW
http://www.aurobindo.com
Telephone
+ 44 (0)208 845 8811
Medical Information e-mail
[email protected]
Customer Care direct line
+44 (0)208 845 8811
Medical Information Fax
+44 (0)208 845 8795